QuestionsQuestions (DEPARTMENT ADMINISTRATIVE ORDER NO. 18-01)
Republic Act No. 595 is an act to amend Item Four of Title M—Department of Health, of Republic Act No. 575, specifically regarding funding for the maintenance, operation, purchase of equipment and materials for manufacturing BCG vaccines in the Alabang Laboratories, and for immunization/protection against tuberculosis.
It amended Item Four of Title M—Department of Health—Special Purposes of Section One of Republic Act No. 575.
The amount stated is Three Hundred Thousand Pesos (₱300,000.00).
Expenses for (1) maintenance, (2) operation, and (3) purchase of equipment and materials for manufacturing BCG vaccines in the Alabang Laboratories, and (4) immunization and protection of the population—especially children—against tuberculosis throughout the Philippines.
It indicates that children are the primary or prioritized beneficiaries of the immunization and protection program against tuberculosis.
In the Alabang Laboratories.
It covers throughout the Philippines.
It funds both vaccine manufacturing (maintenance/operation/equipment/materials in Alabang) and the immunization/protection program for the population.
It modifies the specific budget or allocation provision in RA 575 by replacing the prior Item Four with the amended language and amount stated in RA 595.
It takes effect on January 1, 1951.
To provide retroactive effect for the stated fiscal year/program implementation, aligning the appropriation with the beginning of 1951.
RA 595 does not create an entirely new program structure; instead, it amends a specific budget item within Title M (Department of Health), under Special Purposes of Section One of RA 575.
The policy goal is to immunize and protect the population—especially children—against tuberculosis across the Philippines.
It authorizes spending for (1) operations and maintenance and (2) procurement of equipment and materials for vaccine manufacture, and (3) service delivery for immunization/protection.
It specifies expenses related to maintenance, operation, and purchase of equipment and materials for the manufacture of BCG vaccines in Alabang Laboratories.